愷英網絡(002517.SZ):特定股東及一致行動人減持期屆滿 馮顯超未減持聖盃投資未主動減持
格隆匯10月29日丨愷英網絡(002517.SZ)公佈,截至2019年10月27日,特定股東馮顯超持股2.6047億股(佔公司總股本的12.10%),馮顯超一致行動人聖盃投資持股4153.5728萬股(佔公司總股本的1.93%),減持計劃時間已屆滿,馮顯超未減持公司股份,聖盃投資未發生主動減持。但聖盃投資所持部分股份因股票質押式回購業務違約,被動減持3918.46萬股,佔公司總股本的1.82%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.